Okay, let's tackle this question. The question is about surfactant and its composition. First, I need to recall what surfactant is. Surfactant in the lungs, right? It's a substance that reduces surface tension in the alveoli to prevent them from collapsing. Now, what's it made of? The main components are phospholipids, proteins, and some carbohydrates. The primary phospholipid is phosphatidylcholine, specifically dipalmitoylphosphatidylcholine (DPPC). The proteins are called surfactant proteins (SP-A, SP-B, SP-C, SP-D), which help stabilize the surfactant and have immune functions.

The correct answer here is likely to be an option that includes phospholipids and proteins. Let's see the options. The user didn't list the options, but common distractors might include things like glycoproteins, mucopolysaccharides, or other lipids. For example, if an option lists glycoproteins as the main component, that's incorrect because the main component is phospholipids. Another wrong option might be mucopolysaccharides, which are different from surfactant components. Also, if someone confuses surfactant with mucus, they might pick a different composition.

Wait, the user's correct answer is missing, but the structure of the explanation needs to be based on the correct answer. Let's assume the correct answer is phospholipids and surfactant proteins. Then the wrong options could be other substances. For example, Option A might be glycoproteins, which are not the main component. Option B could be mucopolysaccharides, which are not part of surfactant. Option C might be a mix of proteins and glycolipids, which isn't accurate. Option D could be phospholipids and proteins, which is correct.

The core concept here is the composition of pulmonary surfactant. The key point is that surfactant is primarily composed of phospholipids (especially DPPC) and surfactant proteins. The clinical pearl would be that deficiency in surfactant leads to respiratory distress syndrome in preterm infants, which is why surfactant replacement therapy is used.

So, putting it all together, the correct answer is the option that lists phospholipids and surfactant proteins. The incorrect options would be other combinations that don't include these main components. The clinical pearl is the association with RDS and the therapy involved.

**Core Concept**
Pulmonary surfactant is a lipid-protein complex secreted by type II alveolar cells. Its primary function is to reduce alveolar surface tension via the major phospholipid **dipalmitoylphosphatidylcholine (DPPC)** and surfactant proteins (SP-A, SP-B, SP-C, SP-D).

**Why the Correct Answer is Right**
The correct answer identifies surfactant as composed of **phospholipids (70-80%)**, predominantly DPPC, and **surfactant proteins (5-10%)**. These proteins (SP-B and SP-C) stabilize the phospholipid monolayer, while SP-A and SP-D modulate immune responses. The remaining 10-

✓ Correct Answer: C. Phospholipids